이차성 기질화 폐렴이 동반된 피부근염 1예
A Case of Dermatomyositis with Secondary Organizing Pneumonia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Dermatomyositis is characterized by progressive, symmetric, proximal muscle weakness and a nonsuppurative inflammatory myopathy of unknown etiology involving predominantly skeletal muscles. It is also characterized by typical skin lesions. Interstitial lung disease has a poor prognosis when it is associated with dermatomyositis. Organizing pneumonia is a disease in which granulation tissue fills the lumina of terminal and respiratory bronchioles and extends into the distal airspaces. The cryptogenic nature of the process is appreciated in that organizing pneumonia patterns of injury can be seen in secondary forms of the disease (secondary organizing pneumonia). Organizing pneumonia has been reported to occur in 5∼10% in dermatomyositis-polymyositis patients. Anti-histidyl tRNA synthetase antibody (anti-Jo-1) is a predictive disease marker that is reported to occur in up to 70% of patients. We describe a 49-year-old male dermatomyositis patient who presented with organizing pneumonia and was found to have negative anti-Jo-1 antibody.
Abstract
Dermatomyositis is characterized by progressive, symmetric, proximal muscle weakness and a nonsuppurative inflammatory myopathy of unknown etiology involving predominantly skeletal muscles. It is also characterized by typical skin lesions. Interstitial lung disease has a poor prognosis when it is associated with dermatomyositis. Organizing pneumonia is a disease in which granulation tissue fills the lumina of terminal and respiratory bronchioles and extends into the distal airspaces. The cryptogenic nature of the process is appreciated in that organizing pneumonia patterns of injury can be seen in secondary forms of the disease (secondary organizing pneumonia). Organizing pneumonia has been reported to occur in 5∼10% in dermatomyositis-polymyositis patients. Anti-histidyl tRNA synthetase antibody (anti-Jo-1) is a predictive disease marker that is reported to occur in up to 70% of patients. We describe a 49-year-old male dermatomyositis patient who presented with organizing pneumonia and was found to have negative anti-Jo-1 antibody.
참고문헌 (14)
- Epler GR, "Bronchiolitis obliterans organizing pneumonia", N Egl J Med, 312(3), pp.1152~158 (1985)
- Frazier AR, "Interstitial pneumonitis in association with polymyositis and dermatomyositis", The American college of chest physician, 65(4), pp.403~407 (1974)
- Medsger TA Jr, "Factors affecting survivorship in polymyositis:A life table study of 124 patients", Arthritis Rheum, 14(2), pp.249~258 (1971)
- Marie I, "Interstitial lung disease in polymyositis and dermatomyositis", Arthritis Rheum, 47(6), pp.614~622 (2002)
- Logan RG, "Polymyositis, a clinical study", Ann Int Med, 65(5), pp.996~1007 (1966)
- Mills ES, "Interstitial pneumonitis in dermatomyositis", JAMA, 28160(17), pp.1467~1470 (1956)
- Dickey BF, "Pulmonary disease in polymyositis", dermatomyositis, 1984, pp.14(1), 60~76
- Tazelaar HD, "Interstitial lung disease in polymyositis and dermatomyositis: Clinical features and prognosis as correlated with histologic findings", Am Rev Respir Dis, 141, pp.727~733 (1990)
- Hsue YT, "Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival", J Rheumatol, 20(50), pp.877~879 (1993)
- 이두희, "간질성 폐질환이 동반된 근침범이 없는 피부근염 1예", 대한류마티스 학회지, 6(1), pp.85~90 (1999)
- 윤재영, "피부근염 환자에서 빠르게 진행한 간질성폐렴 1예", 대한류마티스학회지, 14(4), pp.401~406 (2007), 대한류마티스학회
- Kubo M, "Serum KL-6 in adult patients with polymyositis and dermatomyositis", Rheumatology, 39(6), pp.632~636 (2000)
- Ihn H, "Clinical significance of serum surfactant protein(SP-D) in patient with polymyositis", dermatomyositis correlation with interstitial lung disease, 2002, pp.41(11), 1268~1272
- Bradley WG, "Inflammatory disease of muscle, Text book of rheumatology", pp.1255~ (1981), WB Saunders Co